Purchase our cardiovascular disorders module on a standalone basis or together with other modules and solutions across our full portfolio to create an integrated, tailor-made research platform.
GlobalData's Cardiovascular Disorders module delivers data and analysis across a range of high-profile and niche indications.
During the next five years, the value of the leading drug class in this space – antihypertensives – will continue to decline as a result of generic erosion. While drug makers have sought to ward off this decline through various lifecycle management strategies, the future of the mature cardiovascular space lies in the pipeline.
Our therapy module includes coverage from prevalent diseases such as heart failure to rare indications such as orthostatic hypotension.